cp wire

CP Wire Articles

Vedanta Biosciences Announces Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate

Vedanta Biosciences announced on 11/6/18 preclinical data for VE800, the Company’s orally-administered, live biotherapeutic product candidate in immuno-oncology. The study showed that VE800... read more

Wed, 11/7/18 - 11:15 pm
admin
Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology


Synlogic, Inc. (Nasdaq: SYBX) announced on 11/6/18 the presentation of preclinical data from its first immuno-oncology (IO) program at the 33rd Annual Meeting & Pre-Conference Programs of... read more

Wed, 11/7/18 - 11:05 pm
admin
SkinBiotix Technology Generates Positive Data in First Two Elements of its Human Study

SkinBioTherapeutics plc (AIM: SBTX) announced on 11/7/18 positive data from the first two elements of its human study which focus on skin irritancy and moisturisation potential.

As... read more

Wed, 11/7/18 - 10:53 pm
admin
Rebiotix and Microbiome Insights Collaborate on a Microbiome IBD Diagnostic Tool to Aid Clinical Development

With a growing body of science linking gut microbiota to inflammatory bowel disease (IBD), a need exists in clinical settings to understand changes in the gut microbial community as they relate to... read more

Wed, 11/7/18 - 01:02 pm
admin
FDA Grants Orphan Drug Designation for Cannabidiol in the Prevention of Ischemia and Reperfusion Injury from Organ Transplantation
  • The FDA also previously granted orphan drug designation for cannabidiol in the treatment of autoimmune hepatitis
  • Revive is developing cannabinoid pharmaceuticals to treat rare... read more
Wed, 11/7/18 - 09:23 am
admin
FDA Clears Two IND Applications for Fortis Therapeutics Novel Anti-CD46 Candidate for Prostate Cancer and Multiple Myeloma
  • In rodents with human prostate cancer, FOR46 eliminated the tumor and led to long-term survival
  • At this point, Fortis is focused on moving a single asset (FOR46) forward
... read more
Tue, 11/6/18 - 09:23 am
admin
Seattle Genetics Submits Supplemental BLA for Adcetris in T-Cell Lymphomas
  • PTCL accounts for approximately 10 percent of non-Hodgkin lymphoma cases in the U.S. and Europe
  • It may account for as much as 24 percent in parts of Asia.


Seattle... read more

Mon, 11/5/18 - 10:08 am
admin
Mount Sinai and AllerGenis Partner to Develop Novel, Precision Diagnostics For Food Allergy Testing
  • More than 30 million people in the US and Europe suffer from food allergies
  • One in 13 U.S. children are at risk for life-threatening anaphylaxis
  • AllerGenis is creating the... read more
Mon, 11/5/18 - 09:53 am
admin
MaaT Pharma Releases Results Of Microbiome Restoration Therapy in Acute Myeloid Leukemia Patients
  • Microbiome diversity returned 10 days after FMT administration
  • The therapy appeared to have an anti-imflammatory impact

AML standard intensive induction chemotherapy... read more

Fri, 11/2/18 - 09:34 am
admin
The Moore Foundation Announces 6 Year $85 Million Program to Improve Diagnostic Performance
  • Diagnostic errors result in an estimated 40,000 to 80,000 deaths per year
  • Three clinical categories – cardiovascular events, infections and cancers – are responsible for a... read more
Thu, 11/1/18 - 11:05 am
admin
Chinese Biotech Bio-Thera Solutions Initiates Ph III Trial of HER2 ADC in Metastatic Breast Cancer
  • BAT8001 is also being studied gastric cancers
  • Bio-Thera recently announced that is BLA for a Humira biosimilar had been accepted for review in China
  • The company is also... read more
Thu, 11/1/18 - 09:52 am
admin
Microbiome Report for Week Ending 10/27/18

Microbiome Biotech Enterome and Takeda sign Crohn'... read more

Wed, 10/31/18 - 12:39 pm
admin
Shavit Capital Raises $100 Million Fund Focused on Life Sciences

Shavit Capital announced on 10/31/18 the completion of a $100 million funding round for its fifth fund. Founded and managed by Gary Leibler, Shavit Capital has over $400 million under management... read more

Wed, 10/31/18 - 11:31 am
admin
Arrowhead Pharmaceuticals Closes Agreements with Janssen Worth Up To $3.7 Billion
  • Arrowhead will receive $175 million upfront
  • J&J will make a $75 million equity investment
  • Janssen receives a worldwide exclusive license to the ARO-HBV program
    • ... read more
Wed, 10/31/18 - 10:25 am
admin
Gilead Sciences and Tango Therapeutics Form Partnership Worth Up to $1.7 Billion to Develop Next-Gen Immuno-Oncology Therapies
  • Tango will receive $50 million up front
  • The company could receive up to $1.7 billion in additional payments
  • The partnership will focus on building a pipeline of novel immuno... read more
Wed, 10/31/18 - 09:34 am
admin
CymaBay Initiates Ph III Study of Primary Biliary Cholangitis Drug
  • 1 in 1000 women over the age of 40 lives with PBC
  • The company also has clinical trials underway for NASH


CymaBay Therapeutics, Inc. (NASDAQ: CBAY), today announced... read more

Tue, 10/30/18 - 10:23 am
admin
Janssen Unveils Positive Ph III Results for Symtuza in HIV-1 Patients


 
Janssen Pharmaceutical today unveiled 96-week results from the pivotal Phase 3 AMBER study of Symtuza (darunavir 800 mg, cobicistat 150 mg, emtricitabine 200 mg and tenofovir alafenamide... read more

Tue, 10/30/18 - 09:53 am
admin
U.S. DOD Purchases Banyan Biomarkers' Brain Injury Blood Tests
  • Banyan BTI is the first test to aid in the diagnosis of concussion
  • The U.S. CDC estimates there are more than 2.5 million emergency room visits annually in the U.S. alone
... read more
Tue, 10/30/18 - 09:44 am
admin
Innovate Biopharmaceuticals Announces Promising Results of Larazotide in NASH Study
  • Larazotide is a tight junction regulator
  • The drug is also in Ph III trials for celiac disease
  • The FDA awarded fast track status to Larazotide for celiac
  • If approved... read more
Mon, 10/29/18 - 09:45 am
admin
Could Artificial Emotional Intelligence Platform Detect the First Signs of a Heart Attack?
  • Framework may also help protect dementia patients
  • One researcher attributes Watson's failure in cancer diagnosis to a lack of emotion in the data


BPU Holdings... read more

Mon, 10/29/18 - 09:17 am
admin

Pages



current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.